Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods for drug discovery using stem cell-derived schwann cells

a technology of drug discovery, which is applied in the field of drug discovery using stem cell-derived schwann cells, can solve the problems of increased morbidity and mortality, no effective treatment of dpn, and reduced quality of li

Pending Publication Date: 2019-10-31
MEMORIAL SLOAN KETTERING CANCER CENT +1
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It represents a major health problem causing reduced quality of life and increased morbidity and mortality (La Fontaine et al., 2014).
There are currently no effective treatments for DPN other than pursuing the primary goal of preventing further damage by carefully monitoring and adjusting glucose levels.
Dissecting cell type specific mechanisms is very challenging in current animal models of DPN given the complex contribution of non-cell autonomous factors including systemic vascular abnormalities to the disease phenotype.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for drug discovery using stem cell-derived schwann cells
  • Methods for drug discovery using stem cell-derived schwann cells
  • Methods for drug discovery using stem cell-derived schwann cells

Examples

Experimental program
Comparison scheme
Effect test

example 1

SUMMARY

[0214]Schwann cell precursors and Schwann Cells were derived from human stem cells (e.g., hPSC). The inventors established an hESC-based in vitro model of DPN that revealed the selective vulnerability of human SCs to hyperglycemia-induced cytotoxicity and activation of the polyol pathway. The inventors further used this model to perform high throughput drug screening and identified Bupropion as a compound for treatment of DPN. Bupropion can counteract the high-glucose induced cytotoxicity in SCs in vitro and rescues the neuropathy related histological and behavioral deficits in STZ-treated diabetic mice.

Methods and Materials

[0215]Culture of Undifferentiated Human Embryonic Stem Cells (hESCs)

[0216]hESC line H9 (WA-09) and derivatives (SOX10::GFP; SYN::ChR2-YFP; SYN::YFP;PHOX2B:GFP; EF1::RFP EDNRB− / −) as well as 2 independent hiPSC lines (healthy and Familial Dysautonomia, Sendai-based, OMSK (Cytotune)) were maintained on mouse embryonic fibroblasts (MEF, Global Stem, Rockville...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

The presently disclosed subject matter relates to use of Schwann cell precursors and Schwann cells derived from stem cells (e.g., human stem cells) for drug discovery in regeneration of peripheral nervous system (PNS) and / or central nervous system (CNS), prevention and / or repair myelin damages, and / or prevention and / or treatment of Schwann cell-related disorder (e.g., peripheral neuropathy diabetic peripheral neuropathy).

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application is a Continuation of International Patent Application No. PCT / US17 / 61549 filed Nov. 14, 2017, which claims priority to U.S. Application No. 62 / 421,816 filed Nov. 14, 2016, and the contents of each of which are hereby incorporated by reference in their entireties herein, and to each of which priority is claimed.INTRODUCTION[0002]The presently disclosed subject matter relates to use of Schwann cell precursors and Schwann cells derived from stem cells (e.g., human stem cells) for drug discovery in regeneration of peripheral nervous system (PNS) and / or central nervous system (CNS), prevention and / or repair of myelin damages, and / or prevention and / or treatment of Schwann cell-related disorder (e.g., peripheral neuropathy diabetic peripheral neuropathy). It further provides for methods of treatment of Schwann cell related disorders using compounds identified by said drug discovery materials and methods.BACKGROUND[0003]Schwann c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): G01N33/50C12N5/079
CPCC12N5/0622C12N2506/02G01N33/5038C12N2501/115G01N33/5058C12N2501/01A61K35/30A61P19/00A61K35/28C12N2501/15C12N2501/415G01N33/5073C12N5/0062C12N2501/113C12N2501/117C12N2501/119C12N2501/999C12N2513/00
Inventor STUDER, LORENZFATTAHI, FARANAKGHAZIZADEH, ZANIARCHEN, SHUIBING
Owner MEMORIAL SLOAN KETTERING CANCER CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com